Ginkgo Bioworks Holdings (DNA) Consolidated Net Income (2020 - 2026)

Ginkgo Bioworks Holdings has reported Consolidated Net Income for 7 years, with the latest figure at -$6.5 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income rose 14.63% year-over-year to -$6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$228.3 million (up 41.27% YoY), and the FY2025 full-year result was -$312.8 million, up 42.83% from the prior year.
• Consolidated Net Income for Q1 2026 stood at -$6.5 million, up from -$80.8 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$6.5 million in Q1 2026, with the low at -$670.6 million in Q2 2022.
• Historically, Consolidated Net Income has averaged -$222.5 million across 5 years, with a median of -$173.1 million in 2022.
• Annual changes were most pronounced in 2022 — Consolidated Net Income tumbled 1131.22% — and 2025, when it soared 95.39%.
• Ginkgo Bioworks Holdings' Consolidated Net Income stood at -$173.1 million in 2022, then fell by 22.31% to -$211.7 million in 2023, then surged by 49.2% to -$107.5 million in 2024, then gained by 24.91% to -$80.8 million in 2025, then surged by 91.92% to -$6.5 million in 2026.
• The last three Consolidated Net Income figures came in at -$6.5 million (Q1 2026), -$80.8 million (Q4 2025), and -$80.8 million (Q3 2025), per Business Quant data.